Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT

K-Number: K993821 · 1999-12-09

ApplicantMetron Medical Australia, Pty, Ltd.
Decision Date1999-12-09
Product CodeIPF
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT is the device name listed in this FDA 510(k) record. The listed applicant is Metron Medical Australia, Pty, Ltd.. It received FDA 510(k) clearance on 1999-12-09 under 510(k) number K993821. The device is classified under product code IPF. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT?

VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT is a medical device that received FDA 510(k) clearance on 1999-12-09. The listed applicant is Metron Medical Australia, Pty, Ltd.. The 510(k) number is K993821.

When did VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT receive FDA 510(k) clearance?

VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT received FDA 510(k) clearance on 1999-12-09, under 510(k) number K993821.

Who is the listed applicant for VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT?

The FDA 510(k) record lists Metron Medical Australia, Pty, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT?

The FDA product code for VECTORSURGE 4 INTERFERENTIAL THERAPY UNIT is IPF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Metron Medical Australia, Pty, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K132137MULTISTIMK124010ACCUSONIC ADVANTAGEK120171ACCUSONIC ADVANTAGEK030880VECTORSONIC, MODEL VU-270K030878ACCOUSONIC, MODEL AS-270K030648VECTORSURGE 5 MODEL 470

View all 17 devices →

Related Devices (Code: IPF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253542Apollo Quattro (APQ-10M)Weero Co., Ltd.K252816High Tone Power therapy (HiToP) (Model: HiToP PNP)Mohammadali NezakatiK260142StimelMD (SSMD) systemMotion Informatics ltd.K251083Compact IIEnraf-Nonius, B.V.K241433EVE Synergy (EVE-20M)Weero Co., Ltd.K241488TrainFES AdvanceTrainfes

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑